CORRECTING and REPLACING Bristol‑Myers Squibb Announces Dividend

Monday, March 2, 2020 8:52 pm EST

Dateline:

NEW YORK

Public Company Information:

NYSE:
BMY

NEW YORK--(BUSINESS WIRE)--Headline of release should read: "Bristol‑Myers Squibb Announces Dividend" instead of "Bristol‑Myers Squibb Announces Dividend Increase"

The corrected release reads:

BRISTOL‑MYERS SQUIBB ANNOUNCES DIVIDEND

The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty-five cents ($0.45) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on May 1, 2020, to stockholders of record at the close of business on April 3, 2020.

The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable June 1, 2020 to stockholders of record at the close of business on May 5, 2020.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

Multimedia Files:

Preview image

Contact:

Media:
media@bms.com
609-252-3345

Investors:
Tim Power, 609-252-7509, timothy.power@bms.com
Nina Goworek, 908-673-9711, ngoworek@celgene.com

Privacy Policy
Business Wire NewsHQsm